Home / People / Dr. Jörn Witt

Dr. Jörn Witt, LL.M. (University of London)

Partner
Rechtsanwalt | Head of Intellectual Property Group, CMS Germany

Jörn Witt

Dr. Jörn Witt, LL.M. (University of London)

Partner
Rechtsanwalt | Head of Intellectual Property Group, CMS Germany

T +49 40 37630 339
F +49 40 37630 40574
CMS Hasche Sigle
Stadthausbrücke 1-3
20355 Hamburg
Germany
Languages English

Jörn Witt focuses on the life sciences industry and advises pharmaceutical companies, medical device manufacturers as well as companies in related regulated industries. He particularly concentrates on regulatory and reimbursement matters and also assists his clients with drafting and negotiating cooperation and development agreements for business development purposes. Jörn furthermore represents his clients in contentious cases and regularly advises on transactions in the life sciences sector.

Jörn’s practice covers licensing and pharmaceutical laws as well as drugs and medical devices advertising law. He also advises his clients on statutory health insurance law issues, in particular in the context of new forms of care. Across all industries, Jörn furthermore advises on intellectual property matters with a focus on trademark and competition law as well as anti-counterfeiting campaigns.

He joined CMS in 2006 and has been a partner since 2013.


more less

Education


  • Completed his PhD as a German Academic Scholarship Foundation scholar; topic: broadcasting law
  • 2006: Second state examination in law
  • Trainee lawyer in Hamburg
  • 2001 - 2004: Research assistant for Prof. Dr. Hubertus Gersdorf, University of Rostock
  • LL.M. at Queen Mary University of London as a German Academic Exchange Service scholar
  • 2000: First state examination in law
  • Law studies in Hamburg

more less

Publications


  • Unlautere Nachahmung eines Medizinproduktes – Femur-Teil, zugleich Anmerkung zum BGH-Urteil vom 15.4.2010 - I ZR 145/08; MPR 2011, 42
  • Internet-Aktivitäten öffentlich-rechtlicher Rundfunkanstalten, Duncker & Humblot 2007

more less

Expertise

Feed

Show only
15/08/2014
CMS ad­vises IBL In­ter­na­tion­al on its dis­pos­al to Tecan...
#
Press release Corporate / M&A
01/08/2014
CMS ad­vises Almir­all on multi-bil­lion ac­quis­i­tion of...
#
Press release Mergers & Acquisitions
08/01/2013
CMS Hasche Sigle 2013: Six new part­ners ap­poin­ted
#
Press release